COVID-19 in pregnancy: Perinatal outcomes and complications

doi:10.5501/wjv.v13.i4.96573

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

HTML

Tables (1-2)

Sum=0

Dec 25, 2024 (publication date) through Oct 18, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Virol. Dec 25, 2024; 13(4): 96573
Published online Dec 25, 2024. doi: 10.5501/wjv.v13.i4.96573

COVID-19 in pregnancy: Perinatal outcomes and complications

Karolina Akinosoglou, Georgios Schinas, Evangelia Papageorgiou, Theodoros Karampitsakos, Vasiliki Dimakopoulou, Eleni Polyzou, Argyrios Tzouvelekis, Markos Marangos, Despoina Papageorgiou, Nikolaos Spernovasilis, George Adonakis

Karolina Akinosoglou, Georgios Schinas, Vasiliki Dimakopoulou, Eleni Polyzou, Markos Marangos, Despoina Papageorgiou, Department of Medicine, University of Patras, Patras 26504, Greece

Evangelia Papageorgiou, George Adonakis, Department of Obstetrics and Gynecology, University General Hospital of Patras, Patras 26504, Greece

Theodoros Karampitsakos, Argyrios Tzouvelekis, Department of Pneumonology, University General Hospital of Patras, Patras 26504, Greece

Nikolaos Spernovasilis, Department of Infectious Diseases, German Oncology Center, Limassol 4108, Limassol, Cyprus

Author contributions: Akinosoglou K and Adonakis G conceived idea; Schinas G, Papageorgiou E, Karampitsakos T, Dimakopoulou V, and Polyzou E collected data; Schinas G analyzed data; Akinosoglou K and Papageorgiou D wrote manuscript; Akinosoglou K, Tzouvelekis A, Marangos M, and Adonakis G oversaw study; Spernovasilis N critically corrected manuscript; Schinas G and Papageorgiou E equally contributed to this work.

Institutional review board statement: The study was approved by the institute ethics committee of the University Hospital of Patras (Approval No.: 477/24.11.2022).

Informed consent statement: Due to the retrospective type of the study a signed by the participants informed consent form was not necessary.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: No additional data are available.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Nikolaos Spernovasilis, MD, MSc, PhD, Director, Department of Infectious Diseases, German Oncology Center, Nikis 1, Limassol 4108, Limassol, Cyprus. nikspe@hotmaiil.com

Received: May 9, 2024
Revised: August 28, 2024
Accepted: September 6, 2024
Published online: December 25, 2024
Processing time: 161 Days and 10.1 Hours

Core Tip

Core Tip: Pregnant individuals' risk of contracting severe disease from severe acute respiratory syndrome coronavirus 2 infection is elevated. If hospitalization for coronavirus disease 2019 is indicated for expecting mothers, it is crucial the medical treatment to take place in a facility equipped to monitor both maternal and fetal health. Early detection and management of these cases are paramount for optimal results regarding motherhood and newborn care outcomes.